CEFAZOLIN SODIUM

Growth

cefazolin sodium

R-Pharm US
NDAINTRAVENOUSPOWDER
Approved
May 2023
Lifecycle
Growth
Competitive Pressure
30/100

Mechanism of Action

[see Microbiology (12.4)] .

Indications (2)

incidence of certain postoperative infections in patients undergoing surgical procedures which are classifiedpotentially contaminated (e
Company
R-Pharm US
R-Pharm US
NJ - Princeton
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers